Contract Research Organization WCCT Global Announces Launch of a Comprehensive Mobile Phone Friendly Patient Recruitment Program

Costa Mesa, CA (PRWEB) --WCCT Global, a full service CRO and patient recruitment firm announced today implementation of a fully mobile device-friendly digital patient recruitment program to target the ever-growing number of users of mobile devices. In the United States alone, over 190 million people own a smart phone and WCCT Global seized the opportunity to create a comprehensive mobile device recruitment plan, enabling them to successfully convert a large fraction of these users into clinical trial volunteers. The mobile device patient recruitment strategy consists of custom-built applications through web design and social media use to access devices of all sizes and platforms.

This design allows for a seamless experience for the potential volunteer to move through the "education funnel" having been provided with enough information to sign up for the clinical trial of interest without encountering the issues that arise during a recruitment campaign that would not be mobile-friendly. This allows for higher conversion through recruiter access to a larger audience to educate and publicize about the multiple clinical trial opportunities. Since WCCT Global has implemented this plan they have experienced an increase of volunteer sign up submissions jump 800% while decreasing their cost per clinical volunteer lead by over $100 per lead. WCCT Global's Digital Media & Marketing Manager Matt Miller stated, "With today's patient recruitmenttimelines being more aggressive than ever and the sheer user base of mobile devices used as a tool for everyday online tasks, it only seemed appropriate to create a comprehensive recruitment & retention application that we could offer clients to target this large number of smart phone users."

More About WCCT Global

WCCT Global is a multi-site, full-service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, "With compassion for people, we strive for tomorrow's therapies to be available today" truly exemplifies the focus and reason for our cutting-edge work, both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.

If you are interested in learning more about this mobile friendly recruitment design, click here.

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.